TG Therapeutics (TGTX) Tops Q4 EPS by 1c, provides product guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| TG THERAP (NASDAQ: TGTX) | Delayed: 59.95 -1.23 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.18 | 52 Week High | $14.87 | |||
| Open | $61.01 | 52 Week Low | $4.90 | |||
| Day High | $63.60 | P/E | N/A | |||
| Day Low | $59.59 | EPS | $-0.67 | |||
| Volume | 2,576,294 | |||||
